Search Results - "KORTEPETER, C."

Refine Results
  1. 1

    Clinically significant liver injury in patients treated with natalizumab by BEZABEH, S., FLOWERS, C. M., KORTEPETER, C., AVIGAN, M.

    Published in Alimentary pharmacology & therapeutics (01-05-2010)
    “…Aliment Pharmacol Ther 31, 1028–1035 Summary Background  Natalizumab is a recombinant monoclonal antibody approved for the treatment of patients with multiple…”
    Get full text
    Journal Article
  2. 2

    Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs by Bohn, J, Kortepeter, C, Muñoz, M, Simms, K, Montenegro, S, Pan, G Dal

    Published in Clinical pharmacology and therapeutics (01-05-2015)
    “…Spontaneous adverse event reports constitute an important source of information on previously unknown adverse reactions to marketed medicines. However, the…”
    Get full text
    Journal Article
  3. 3

    Renal failure associated with the use of celecoxib and rofecoxib by AHMAD, Syed R, KORTEPETER, Cindy, BRINKER, Allen, MIN CHEN, BEITZ, Julie

    Published in Drug safety (2002)
    “…Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Central Nervous System Herpes Simplex and Varicella Zoster Virus Infections in Natalizumab-Treated Patients by Fine, Andrew J., Sorbello, Alfred, Kortepeter, Cindy, Scarazzini, Linda

    Published in Clinical infectious diseases (15-09-2013)
    “…We report on 20 natalizumab-treated patients with multiple sclerosis who developed laboratory-confirmed central nervous system (CNS) herpesvirus infections. In…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Lamotrigine and aseptic meningitis by SIMMS, Kelley M, KORTEPETER, Cindy, AVIGAN, Mark

    Published in Neurology (20-03-2012)
    “…The purpose of this case series is to characterize a recently identified association of the antiepileptic drug (AED) lamotrigine with aseptic meningitis based…”
    Get full text
    Journal Article
  8. 8

    Seizure Activity and Off-Label Use of Tiagabine by Flowers, Charlene M, Racoosin, Judith A, Kortepeter, Cindy

    Published in The New England journal of medicine (16-02-2006)
    “…To the Editor: Thirty-one case reports of new-onset seizures associated with off-label use of tiagabine (Gabitril) have prompted the addition of a boldface…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Clozapine and Venous Thromboembolism by KORTEPETER, CINDY, CHEN, MIN, KNUDSEN, JAMES F., DUBITSKY, GREG M., AHMAD, SYED R., BEITZ, JULIE

    Published in The American journal of psychiatry (01-05-2002)
    “…A letter to the editor discusses research by Ihde-Scholl et al that reported a case of pulmonary embolism associated with clozapine, an atypical antipsychotic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance by Misu, Takashi, Kortepeter, Cindy M., Muñoz, Monica A., Wu, Eileen, Dal Pan, Gerald J.

    Published in Drugs -- real world outcomes (01-06-2018)
    “…Introduction The most commonly reported adverse event, based on frequency of Medical Dictionary for Regulatory Activities (MedDRA) preferred terms (PTs), in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Possible short-term memory loss associated with nafarelin acetate by Kortepeter, C, Macmillan, M, Ferrell, R

    Published in The Annals of pharmacotherapy (01-02-1992)
    “…A survey was conducted to determine the occurrence of short-term memory loss in patients using nafarelin acetate nasal spray. A list of all patients receiving…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20